Daniella Rahamim-Cohen

Dr. Daniella Rahamim-Cohen

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
BKBoaz Kalmovich
Boaz Kalmovich
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
Antibiotic overuse and underuse are prevalent in urgent care settings, driven in part by diagnostic uncertainty. A host-based test for distinguishing bacterial and viral infections (MeMed BV) has been clinically validated previously. Here we examined how BV impacts antibiotic prescription in a real-world setting. The intention to treat with antibiotics before the receipt of a BV result was compared with practice after the receipt of a BV result at three urgent care centers. The analysis included 152 patients, 57.9% children and 50.7% female. In total, 131 (86.2%) had a bacterial or viral BV result. Physicians were uncertain about prescription for 38 (29.0%) patients and for 30 (78.9%) of these cases, subsequently acted in accordance with the BV result. Physicians intended to prescribe antibiotics to 39 (29.8%) patients, of whom 17 (43.6%) had bacterial BV results. Among the remaining 22 patients with viral BV results, antibiotic prescriptions were reduced by 40.9%. Overall, the physician prescribed in accordance with BV results in 81.7% of all cases (p < 0.05). In total, the physicians reported that BV supported or altered their decision making in 87.0% of cases (p < 0.05). BV impacts patient management in real-world settings, supporting appropriate antibiotic use.

13 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
SGSivan Gazit
Sivan Gazit
GPGalit Perez
Galit Perez
BNBarak Nada
Barak Nada
SMShay Ben Moshe
Shay Ben Moshe
TPTal Patalon
Tal Patalon
Following the widespread vaccination program for COVID-19 carried out in Israel, a survey was conducted to preliminarily assess behavior changes in the vaccinated population, prior to the expected upcoming policy change as to mask wearing and social distancing regulation in Israel. 200 people answered at least one question pertaining to preventive behaviour. Among the respondents, 21.1% reported a decrease in mask wearing compared to 47.3% who reported a decrease in social distancing. There was no difference in these measures between the sexes. However, people under the age of 50 were more likely to decrease mask wearing (28.1%) and decrease social distancing (56.1%), as compared with people over the age of 50 (17.2% and 41.8%, respectively). Among health care workers, there was a minimal decrease in mask wearing (1/23 people) compared to a more widespread decrease in social distancing (10/23). These data suggest that preventive attitudes change following COVID-19 vaccination, with less adherence to social distancing as compared to mask wearing, and should be taken into account when planning public policy in the future.

1 February 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
JKJennifer Kertes
Jennifer Kertes
IFIlana Feldblum
Ilana Feldblum
NSNaama Shamir-Stein
Naama Shamir-Stein
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
Post-COVID-19 has been recognized as possibly affecting millions of people worldwide. In order to optimize care and ensure equality, we established a multidisciplinary virtual Post-COVID-19 clinic (VPCC) within Maccabi Healthcare Services, the second largest HMO in Israel. This study aims to describe the structure, process and patient satisfaction with this clinic. The multidisciplinary team consisted of physicians, physiotherapists, social workers, occupational therapists and dieticians. Patient entry was to be at least four weeks after COVID-19 infection. A patient satisfaction survey was carried out 7–8 months after the clinic was closed. Demographic data were collected and compared to the general Maccabi COVID-19 population. The clinic treated 1614 patients, aged 16–91, over a period of 18 months. In total, 679 family physicians referred patients. In comparison to the general COVID-19 population, a higher percentage of the VPCC patients lived in the periphery of Israel, South (14.9% compared to 17.8%) and North (17.1% compared to 18.2%). In total, 249 patients answered the survey, and of them, 75% were highly satisfied with the medical care of the physician in the VPCC. A total of 54% of respondents would have preferred a face-to-face consultation, but 50% felt that communication was good in the virtual mode. In conclusion, the VPCC provided a dedicated service for patients, and the virtual format made it equally accessible to all parts of the country.

25 July 2025 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
ANAfif Nakhleh
Afif Nakhleh
EREyal Robenshtok
Eyal Robenshtok
LALimor Adler
Limor Adler
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
SZSagit Zolotov
Sagit Zolotov
Context: Transition from hypothyroidism to Graves' disease (GD) is uncommon. Objective: To compare presentation, management, and outcomes of GD after hypothyroidism (post-hypo-GD) with GD controls (no prior thyroid disease). Design: Retrospective cohort 2010 to 2022, followed through October 2024. Setting: Maccabi Healthcare Services, Israeli health maintenance organization. Patients: Adults with incident GD and thyroid-stimulating immunoglobulin activity ≥140% within 1 year of thyrotoxicosis (N = 2402, 256 post-hypo-GD, 2146 GD controls). Excluded prior or current amiodarone users. Interventions: Longitudinal assessment of usual care with antithyroid drugs, radioactive iodine, or total thyroidectomy, and subsequent hypothyroidism requiring levothyroxine. Main Outcome Measures: Usual care treatments and incident hypothyroidism requiring levothyroxine. Results: Compared to GD controls, post-hypo-GD patients were older (51.4 ± 14.3 vs 47.4 ± 13.6 years, P < .001), predominantly female (88.2% vs 76.9%, P < .001), and with higher prevalence of autoimmune disease (19.5% vs 12.9%, P = .003). At diagnosis, post-hypo-GD patients had milder disease with lower median free T4 (21.7 vs 26.8 pmol/L, P < .001) and free T3 (8.5 vs 10.4 pmol/L, P < .001) levels. Over a 7.2-year median follow-up, post-hypo-GD patients were less frequently treated with antithyroid drugs (65.6% vs 81.0%, P < .001). Radioactive iodine ablation and total thyroidectomy use were comparable. Post-hypo-GD patients were more than twice as likely to develop hypothyroidism requiring levothyroxine at the end of follow-up (41.8% vs 21.0%, P < .001). Conclusion: Post-hypo-GD (∼10% of new GD cases) is a distinct, predominantly female phenotype marked by milder thyrotoxicosis, lower antithyroid drug use, and a high rate of relapse into hypothyroidism warranting routine assessment of prior thyroid status and close biochemical monitoring.

27 January 2024 in Vaccine
Verified
Journal Article
Closed access
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
SGSharon Baruch Gez
Sharon Baruch Gez
LALimor Adler
Limor Adler
RKRada Kovatch
Rada Kovatch
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
MMMiri Mizrhi-Reuveni
Miri Mizrhi-Reuveni

12 December 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
BCBar Cohen
Bar Cohen
SDShirley Shapiro Ben David
Shirley Shapiro Ben David
DRDaniella Rahamim-Cohen
Daniella Rahamim-Cohen
ANAfif Nakhleh
Afif Nakhleh
ASArnon Shahar
Arnon Shahar
LALimor Adler
Limor Adler
Introduction: Correlations between SARS-CoV-2 and bacterial infections have mainly been studied in hospitals, and these studies have shown that such interactions may be lethal for many. In the context of community flora, less is known of the trends and consequences of viral infections relative to subsequent bacterial infections. Purpose: This study aims to explore the prevalence and characteristics of bacterial infections in the three months following SARS-CoV-2 infections, in a community, real-world setting. Methods: In this retrospective cohort study, we compared patients who completed a polymerase chain reaction (PCR) test or an antigen test for SARS-CoV-2 during January 2022, the peak of the Omicron wave, and examined bacterial infections following the test. We searched these cases for diagnoses of the following four bacterial infections for three months following the test: Group A Streptococcus (GAS) pharyngitis, pneumonia, cellulitis, and urinary tract infections (UTI). Results: During January 2022, 267,931 patients tested positive and 261,909 tested negative for SARS-CoV-2. Test-positive compared to test-negative patients were significantly younger (42.5 years old vs. 48.5 years old, p < 0.001), smoked less, and had fewer comorbidities (including ischemic heart disease, diabetes mellitus, hypertension, chronic obstructive pulmonary disease, and chronic renal failure). In the multivariable analysis, test-positive patients had an increased risk for GAS pharyngitis (adjusted odds ratio [aOR] = 1.25, 95% CI 1.14–1.38, p-value < 0.001) and pneumonia (aOR = 1.25, 95% CI 1.15–1.35, p-value < 0.001), a trend towards an increased prevalence of UTI (aOR = 1.05, 95% CI 0.99–1.12, p-value = 0.092), and lower risk for cellulitis (aOR = 0.92, 95% CI 0.86–0.99, p-value < 0.05). Conclusions: A history of SARS-CoV-2 infection in the past three months increased susceptibility to respiratory tract bacterial infections and the prevalence of UTI.